Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Association Between Progression of Retinopathy and Concurrent Progression of Kidney Disease: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Grunwald JE, Pistilli M, Ying GS, Daniel E, Maguire M, Xie D, Roy J, Whittock-Martin R, Parker Ostroff C, Lo JC, Townsend RR, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman HI, Kusek JW; Chronic Renal Insufficiency Cohort Study Investigators.

JAMA Ophthalmol. 2019 May 9. doi: 10.1001/jamaophthalmol.2019.1052. [Epub ahead of print]

PMID:
31070679
2.

A Study of Physical Activity Determinants among High-Risk Hypertensive Filipino and Korean Americans.

Bhimla A, Gadegbeku CA, Tan Y, Zhu L, Aczon F, Ma GX.

Int J Environ Res Public Health. 2019 Mar 31;16(7). pii: E1156. doi: 10.3390/ijerph16071156.

3.

Soluble ST2 and Galectin-3 and Progression of CKD.

Alam ML, Katz R, Bellovich KA, Bhat ZY, Brosius FC, de Boer IH, Gadegbeku CA, Gipson DS, Hawkins JJ, Himmelfarb J, Kestenbaum BR, Kretzler M, Robinson-Cohen C, Steigerwalt SP, Tuegel C, Bansal N.

Kidney Int Rep. 2018 Sep 21;4(1):103-111. doi: 10.1016/j.ekir.2018.09.013. eCollection 2019 Jan.

4.

Consent for Genetic Biobanking in a Diverse Multisite CKD Cohort.

Troost JP, Hawkins J, Jenkins DR, Gipson DS, Kretzler M, El Shamy O, Bellovich K, Perumal K, Bhat Z, Massengill S, Steigerwalt S, Pennathur S, Brosius FC, Gadegbeku CA; Michigan O’Brien Kidney Translational Research Center.

Kidney Int Rep. 2018 Jun 12;3(6):1267-1275. doi: 10.1016/j.ekir.2018.06.002. eCollection 2018 Nov.

5.

Dialysis for Patients With End-stage Renal Disease Who Are Homeless.

Novick TK, Gadegbeku CA, Crews DC.

JAMA Intern Med. 2018 Dec 1;178(12):1581-1582. doi: 10.1001/jamainternmed.2018.5470. No abstract available.

6.

Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients.

Jadoon A, Mathew AV, Byun J, Gadegbeku CA, Gipson DS, Afshinnia F, Pennathur S; for the Michigan Kidney Translational Core CPROBE Investigator Group.

Am J Nephrol. 2018;48(4):269-277. doi: 10.1159/000493862. Epub 2018 Oct 16.

PMID:
30326477
7.

Health behavior practice among understudied Chinese and Filipino Americans with cardiometabolic diseases.

Lee M, Hu D, Bunney G, Gadegbeku CA, Edmundowicz D, Houser SR, Wang H, Ma GX.

Prev Med Rep. 2018 Jun 2;11:240-246. doi: 10.1016/j.pmedr.2018.06.004. eCollection 2018 Sep.

8.

Hypertension in African Americans.

Musemwa N, Gadegbeku CA.

Curr Cardiol Rep. 2017 Oct 28;19(12):129. doi: 10.1007/s11886-017-0933-z. Review.

PMID:
29081008
9.

Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.

Afshinnia F, Zeng L, Byun J, Gadegbeku CA, Magnone MC, Whatling C, Valastro B, Kretzler M, Pennathur S; Michigan Kidney Translational Core CPROBE Investigator Group.

Am J Nephrol. 2017;46(1):73-81. doi: 10.1159/000477766. Epub 2017 Jul 1.

10.

Blood Pressure and Visit-to-Visit Blood Pressure Variability Among Individuals With Primary Proteinuric Glomerulopathies.

Sethna CB, Meyers KEC, Mariani LH, Psoter KJ, Gadegbeku CA, Gibson KL, Srivastava T, Kretzler M, Brady TM.

Hypertension. 2017 Aug;70(2):315-323. doi: 10.1161/HYPERTENSIONAHA.117.09475. Epub 2017 Jun 26.

11.

Risk Assessment and Prevention of Hypertension in Filipino Americans.

Ma GX, Lee M, Bhimla A, Tan Y, Gadegbeku CA, Yeh MC, Aczon H.

J Community Health. 2017 Aug;42(4):797-805. doi: 10.1007/s10900-017-0320-0.

12.

Growth Differentiation Factor-15 and Risk of CKD Progression.

Nair V, Robinson-Cohen C, Smith MR, Bellovich KA, Bhat ZY, Bobadilla M, Brosius F, de Boer IH, Essioux L, Formentini I, Gadegbeku CA, Gipson D, Hawkins J, Himmelfarb J, Kestenbaum B, Kretzler M, Magnone MC, Perumal K, Steigerwalt S, Ju W, Bansal N.

J Am Soc Nephrol. 2017 Jul;28(7):2233-2240. doi: 10.1681/ASN.2016080919. Epub 2017 Feb 3.

13.

APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.

Freedman BI, Gadegbeku CA, Bryan RN, Palmer ND, Hicks PJ, Ma L, Rocco MV, Smith SC, Xu J, Whitlow CT, Wagner BC, Langefeld CD, Hawfield AT, Bates JT, Lerner AJ, Raj DS, Sadaghiani MS, Toto RD, Wright JT Jr, Bowden DW, Williamson JD, Sink KM, Maldjian JA, Pajewski NM, Divers J.

Kidney Int. 2016 Aug;90(2):440-449. doi: 10.1016/j.kint.2016.04.027. Epub 2016 Jun 22.

14.

Complete Remission in the Nephrotic Syndrome Study Network.

Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):81-9. doi: 10.2215/CJN.02560315. Epub 2015 Dec 10.

15.

Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.

Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A, Lai JY, Zhou Y, Hawkins JJ, Bitzer M, Sampson MG, Thier M, Solier C, Duran-Pacheco GC, Duchateau-Nguyen G, Essioux L, Schott B, Formentini I, Magnone MC, Bobadilla M, Cohen CD, Bagnasco SM, Barisoni L, Lv J, Zhang H, Wang HY, Brosius FC, Gadegbeku CA, Kretzler M; ERCB, C-PROBE, NEPTUNE, and PKU-IgAN Consortium.

Sci Transl Med. 2015 Dec 2;7(316):316ra193. doi: 10.1126/scitranslmed.aac7071.

16.

Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study).

Grunwald JE, Pistilli M, Ying GS, Maguire M, Daniel E, Whittock-Martin R, Parker-Ostroff C, Mohler E, Lo JC, Townsend RR, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek JW, Xie D; CRIC Study Investigators.

Am J Cardiol. 2015 Nov 15;116(10):1527-33. doi: 10.1016/j.amjcard.2015.08.015. Epub 2015 Aug 31.

17.

Monocyte and plasma expression of TAM ligand and receptor in renal failure: Links to unregulated immunity and chronic inflammation.

Lee IJ, Hilliard BA, Ulas M, Yu D, Vangala C, Rao S, Lee J, Gadegbeku CA, Cohen PL.

Clin Immunol. 2015 Jun;158(2):231-41. doi: 10.1016/j.clim.2015.01.012. Epub 2015 Mar 24.

PMID:
25814173
18.

A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.

Spinale JM, Mariani LH, Kapoor S, Zhang J, Weyant R, Song PX, Wong HN, Troost JP, Gadegbeku CA, Gipson DS, Kretzler M, Nihalani D, Holzman LB; Nephrotic Syndrome Study Network.

Kidney Int. 2015 Mar;87(3):564-74. doi: 10.1038/ki.2014.346. Epub 2014 Oct 29.

19.

Integrative biology identifies shared transcriptional networks in CKD.

Martini S, Nair V, Keller BJ, Eichinger F, Hawkins JJ, Randolph A, Böger CA, Gadegbeku CA, Fox CS, Cohen CD, Kretzler M; European Renal cDNA Bank; C-PROBE Cohort; CKDGen Consortium.

J Am Soc Nephrol. 2014 Nov;25(11):2559-72. doi: 10.1681/ASN.2013080906. Epub 2014 Jun 12.

20.

Retinopathy and progression of CKD: The CRIC study.

Grunwald JE, Pistilli M, Ying GS, Daniel E, Maguire MG, Xie D, Whittock-Martin R, Parker Ostroff C, Lo JC, Townsend RR, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman HI, Kusek JW; Chronic Renal Insufficiency Cohort Study Investigators.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1217-24. doi: 10.2215/CJN.11761113. Epub 2014 May 8.

21.

Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study.

Mariani LH, White MT, Shults J, Anderson CA, Feldman HI, Wolf M, Reese PP, Denburg MR, Townsend RR, Lo JC, Cappola AR, Carlow D, Gadegbeku CA, Steigerwalt S, Leonard MB; CRIC Study Investigators.

J Ren Nutr. 2014 May;24(3):186-93. doi: 10.1053/j.jrn.2014.01.015. Epub 2014 Mar 7.

22.

Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort study.

Mehta NN, Matthews GJ, Krishnamoorthy P, Shah R, McLaughlin C, Patel P, Budoff M, Chen J, Wolman M, Go A, He J, Kanetsky PA, Master SR, Rader DJ, Raj D, Gadegbeku CA, Shah R, Schreiber M, Fischer MJ, Townsend RR, Kusek J, Feldman HI, Foulkes AS, Reilly MP; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Eur Heart J. 2014 Aug 14;35(31):2115-22. doi: 10.1093/eurheartj/eht481. Epub 2013 Dec 4.

23.

Physical performance and frailty in chronic kidney disease.

Reese PP, Cappola AR, Shults J, Townsend RR, Gadegbeku CA, Anderson C, Baker JF, Carlow D, Sulik MJ, Lo JC, Go AS, Ky B, Mariani L, Feldman HI, Leonard MB; CRIC Study Investigators.

Am J Nephrol. 2013;38(4):307-15. doi: 10.1159/000355568. Epub 2013 Oct 4.

24.

Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort).

Ferguson JF, Matthews GJ, Townsend RR, Raj DS, Kanetsky PA, Budoff M, Fischer MJ, Rosas SE, Kanthety R, Rahman M, Master SR, Qasim A, Li M, Mehta NN, Shen H, Mitchell BD, O'Connell JR, Shuldiner AR, Ho WK, Young R, Rasheed A, Danesh J, He J, Kusek JW, Ojo AO, Flack J, Go AS, Gadegbeku CA, Wright JT Jr, Saleheen D, Feldman HI, Rader DJ, Foulkes AS, Reilly MP; CRIC Study Principal Investigators.

J Am Coll Cardiol. 2013 Aug 27;62(9):789-98. doi: 10.1016/j.jacc.2013.01.103. Epub 2013 May 30.

25.

A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study.

Bansal N, Keane M, Delafontaine P, Dries D, Foster E, Gadegbeku CA, Go AS, Hamm LL, Kusek JW, Ojo AO, Rahman M, Tao K, Wright JT, Xie D, Hsu CY; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2013 Mar;8(3):355-62. doi: 10.2215/CJN.06020612. Epub 2013 Feb 14.

26.

Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.

Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, Nast CC, Neu AM, Reich HN, Sedor JR, Sethna CB, Trachtman H, Tuttle KR, Zhdanova O, Zilleruelo GE, Kretzler M.

Kidney Int. 2013 Apr;83(4):749-56. doi: 10.1038/ki.2012.428. Epub 2013 Jan 16.

27.

Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study.

Grunwald JE, Alexander J, Ying GS, Maguire M, Daniel E, Whittock-Martin R, Parker C, McWilliams K, Lo JC, Go A, Townsend R, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek JW, Xie D, Jaar BG; CRIC Study Group.

Arch Ophthalmol. 2012 Sep;130(9):1136-44.

28.

Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure.

Lee IJ, Hilliard B, Swami A, Madara JC, Rao S, Patel T, Gaughan JP, Lee J, Gadegbeku CA, Choi ET, Cohen PL.

Nephrol Dial Transplant. 2012 Nov;27(11):4166-72. doi: 10.1093/ndt/gfs337. Epub 2012 Aug 20.

29.

Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study).

Grunwald JE, Ying GS, Maguire M, Pistilli M, Daniel E, Alexander J, Whittock-Martin R, Parker C, Mohler E, Lo JC, Townsend R, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek JW, Xie D, Coleman M, Keane MG; Chronic Renal Insufficiency Cohort (CRIC) Study Group.

Am J Cardiol. 2012 Jul 15;110(2):246-53. doi: 10.1016/j.amjcard.2012.03.014. Epub 2012 Apr 18.

30.

Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase.

von Leitner EC, Klinke A, Atzler D, Slocum JL, Lund N, Kielstein JT, Maas R, Schmidt-Haupt R, Pekarova M, Hellwinkel O, Tsikas D, D'Alecy LG, Lau D, Willems S, Kubala L, Ehmke H, Meinertz T, Blankenberg S, Schwedhelm E, Gadegbeku CA, Böger RH, Baldus S, Sydow K.

Circulation. 2011 Dec 13;124(24):2735-45. doi: 10.1161/CIRCULATIONAHA.111.060541. Epub 2011 Nov 14.

PMID:
22082678
31.

Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease.

Scialla JJ, Leonard MB, Townsend RR, Appel L, Wolf M, Budoff MJ, Chen J, Lustigova E, Gadegbeku CA, Glenn M, Hanish A, Raj D, Rosas SE, Seliger SL, Weir MR, Parekh RS; CRIC Study Group.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2612-9. doi: 10.2215/CJN.03910411. Epub 2011 Sep 22.

32.

Vitamin D and subsequent systolic hypertension among women.

Griffin FC, Gadegbeku CA, Sowers MR.

Am J Hypertens. 2011 Mar;24(3):316-21. doi: 10.1038/ajh.2010.226. Epub 2010 Nov 18.

PMID:
21088670
33.

Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study.

Townsend RR, Chirinos JA, Parsa A, Weir MA, Sozio SM, Lash JP, Chen J, Steigerwalt SP, Go AS, Hsu CY, Rafey M, Wright JT Jr, Duckworth MJ, Gadegbeku CA, Joffe MP; Chronic Renal Insufficiency Cohort Investigators.

Hypertension. 2010 Sep;56(3):518-24. doi: 10.1161/HYPERTENSIONAHA.110.153924. Epub 2010 Jul 26. Erratum in: Hypertension. 2012 Jan;59(1):e3-5.

34.

Prevalence of ocular fundus pathology in patients with chronic kidney disease.

Grunwald JE, Alexander J, Maguire M, Whittock R, Parker C, McWilliams K, Lo JC, Townsend R, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek J, Ojo A; CRIC Study Group.

Clin J Am Soc Nephrol. 2010 May;5(5):867-73. doi: 10.2215/CJN.08271109. Epub 2010 Mar 18.

35.

Aortic PWV in chronic kidney disease: a CRIC ancillary study.

Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, Lash JP, Chen J, Steigerwalt SP, Flack J, Go AS, Rafey M, Rahman M, Sheridan A, Gadegbeku CA, Robinson NA, Joffe M.

Am J Hypertens. 2010 Mar;23(3):282-9. doi: 10.1038/ajh.2009.240. Epub 2009 Dec 17.

36.

Aortic pulse pressure is associated with carotid IMT in chronic kidney disease: report from Chronic Renal Insufficiency Cohort.

DeLoach SS, Appel LJ, Chen J, Joffe MM, Gadegbeku CA, Mohler ER 3rd, Parsa A, Perumal K, Rafey MA, Steigerwalt SP, Teal V, Townsend RR, Rosas SE.

Am J Hypertens. 2009 Dec;22(12):1235-41. doi: 10.1038/ajh.2009.156. Epub 2009 Sep 24. Erratum in: Am J Hypertens. 2010 Apr;23(4):449. Am J Hypertens. 2011 Dec;24(12):1346.

37.

Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans.

Valiña-Tóth AL, Lai Z, Yoo W, Abou-Samra A, Gadegbeku CA, Flack JM.

Clin Endocrinol (Oxf). 2010 May;72(5):595-603. doi: 10.1111/j.1365-2265.2009.03676.x. Epub 2009 Jul 28.

38.

Cum hoc, ergo propter hoc: health disparities real and imagined.

Gadegbeku CA, Chertow GM.

Clin J Am Soc Nephrol. 2009 Feb;4(2):251-3. doi: 10.2215/CJN.06361208. No abstract available.

39.

Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.

Billecke SS, D'Alecy LG, Platel R, Whitesall SE, Jamerson KA, Perlman RL, Gadegbeku CA.

Nephrol Dial Transplant. 2009 Feb;24(2):489-96. doi: 10.1093/ndt/gfn500. Epub 2008 Sep 15.

40.

Arterial compliance in adolescents and young adults receiving chronic hemodialysis.

Gbadegesin R, Kudelka T, Gadegbeku CA, Brophy P, Smoyer WE, Lin JJ.

Ren Fail. 2008;30(6):591-6. doi: 10.1080/08860220802132064.

PMID:
18661408
41.

Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension.

Gadegbeku CA, Stillman PK, Huffman MD, Jackson JS, Kusek JW, Jamerson KA.

Contemp Clin Trials. 2008 Nov;29(6):837-42. doi: 10.1016/j.cct.2008.06.001. Epub 2008 Jun 27.

42.

Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease.

Gadegbeku CA, Dhandayuthapani A, Taylor TP, Shrayyef Z, Gerich J, Garvey WT, Egan BM.

J Am Soc Hypertens. 2007 Nov-Dec;1(6):414-22. doi: 10.1016/j.jash.2007.05.004.

PMID:
20409874
43.

Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension.

Gadegbeku CA, Shrayyef MZ, Taylor TP, Egan BM.

J Hypertens. 2006 Jul;24(7):1383-9.

PMID:
16794488
44.

Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure management.

Lash JP, Wang X, Greene T, Gadegbeku CA, Hall Y, Jones K, Kusek JW, Sika M, Unruh M; African American Study of Kidney Disease and Hypertension Trial Study Group.

Am J Kidney Dis. 2006 Jun;47(6):956-64.

PMID:
16731290
45.

Update on disparities in the pathophysiology and management of hypertension: focus on African Americans.

Gadegbeku CA, Lea JP, Jamerson KA.

Med Clin North Am. 2005 Sep;89(5):921-33, 930. Review.

PMID:
16129104
46.

Glomerular filtration rate can be accurately predicted using lean mass measured by dual-energy X-ray absorptiometry.

Taylor TP, Wang W, Shrayyef MZ, Cheek D, Hutchison FN, Gadegbeku CA.

Nephrol Dial Transplant. 2006 Jan;21(1):84-7. Epub 2005 Aug 22.

PMID:
16115844
47.

Effects of intravenously administered iron on systemic blood pressure in hemodialysis patients.

Ullian ME, Gadegbeku CA.

Nephron Clin Pract. 2004;98(3):c83-6.

PMID:
15528942
48.

Lipids enhance alpha1-adrenoceptor pressor sensitivity in patients with chronic kidney disease.

Gadegbeku CA, Shrayyef MZ, LaPorte FB, Egan BM.

Am J Kidney Dis. 2004 Sep;44(3):446-54.

PMID:
15332217
49.

Hemodynamic effects of chronic hemodialysis therapy assessed by pulse waveform analysis.

Gadegbeku CA, Shrayyef MZ, Ullian ME.

Am J Hypertens. 2003 Oct;16(10):814-7.

PMID:
14553959
50.

Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects.

Gadegbeku CA, Dhandayuthapani A, Shrayyef MZ, Egan BM.

Am J Hypertens. 2003 Jan;16(1):67-71.

PMID:
12517686

Supplemental Content

Loading ...
Support Center